In this interview with one of retina’s true giants, Mike Trese, MD, details his remarkable 45-year career spearheading revolutionary developments in both pediatric and adult retina. He shares the challenges of navigating blinding diseases with the youngest and most vulnerable patients and the amazing advances that have increased the success rate for retinopathy of prematurity (ROP) from 50% to 90%. He also touches on his strong desire to make a contribution to the field and to his patients that has spawned the development of key innovations in retinal instrumentation and surgery.Learn more at www.retinahistory.asrs.org.About the History of RetinaThe History of Retina is brought to you by the Foundation of the American Society of Retina Specialists (ASRS) in an effort to preserve the history and heritage of retina for generations to come. Trace the journey of the specialty's dynamic evolution by exploring milestones in technology, instrumentation, and techniques and hearing first-hand accounts from retina pioneers whose innovative spirit and pivotal contributions laid the framework for the advanced sight-saving retinal care of today and the enormously promising treatments of tomorrow.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related